Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KBP-5074 in chronic kidney disease with uncontrolled hypertension
NCT03574363Phase 2Completed
- Sponsor
- KBP Biosciences
- Start
- Apr 2018
- Primary completion
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ocederenone in hypertension (HTN), sponsored by KBP Biosciences. Started Apr 2018; status: completed.
02
Drugs
ocederenone
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT03574363.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03574363.